`Friday, November 20, 2020 3:32 PM
`Ferguson, Brian; James, William G.; Cipriano, Linnea P; Weinger, Joshua
`Weiswasser, Elizabeth; Desai, Anish; Pepe, Christopher; Kennedy, Natalie; Gesior,
`Andrew
`RE: IPR2020-01318 (Regeneron v Novartis)
`
`From:
`Sent:
`To:
`Cc:
`
`Subject:
`
`Hi Brian,
`
`Patent Owner does not oppose. We are available for a call with the Board Monday after 2 pm, Tuesday after 1 pm and
`Wednesday before 11 am.
`
`Best regards,
`
`From: Ferguson, Brian <brian.ferguson@weil.com>
`Sent: Friday, November 20, 2020 10:45 AM
`To: Holland, Elizabeth J. <EHolland@goodwinlaw.com>; James, William G. <WJames@goodwinlaw.com>; Cipriano,
`Linnea P <LCipriano@goodwinlaw.com>; Weinger, Joshua <JWeinger@goodwinlaw.com>
`Cc: Weiswasser, Elizabeth <Elizabeth.Weiswasser@weil.com>; Desai, Anish <anish.desai@weil.com>; Pepe, Christopher
`<Christopher.Pepe@weil.com>; Kennedy, Natalie <Natalie.Kennedy@weil.com>; Gesior, Andrew
`<Andrew.Gesior@weil.com>
`Subject: IPR2020‐01318 (Regeneron v Novartis)
`
`IPR2020‐01318
`Patent 9,220,631 B2
`
`Elizabeth and Team:
`
`Regeneron intends to file a motion requesting that the Board terminate the proceedings in IPR2020‐01318 pursuant to
`37 C.F.R. §§ 42.5(a), 42.71(a). Because the Board has not yet determined whether to institute a trial, dismissal of the
`Petition and termination of the proceedings will preserve the resources of the Board and the parties, and will promote
`efficiency as contemplated by 37 C.F.R. § 42.1(b). Regeneron’s motion will be directed solely to the proceedings in
`IPR2020‐01318, and not co‐pending IPR2020‐01317.
`
`Please let us know whether Patent Owner will oppose the motion, and also your availability for a call with Board next
`week (Monday – Wednesday). Have a nice weekend.
`
`Best regards,
`
`Brian
`
`1
`
`Regeneron Exhibit 1066.001
`Regeneron v. Novartis
`IPR2020-01318
`
`
`
`Brian E. Ferguson
`Co-Head, Patent Litigation Group
`
`Weil, Gotshal & Manges LLP
`2001 M Street NW, Suite 600
`Washington, DC 20036
`brian.ferguson@weil.com
`+1 202 682 7516 Direct
`+1 301 801 8870 iPhone
`
`The information contained in this email message is intended only for use of the individual or entity named above. If the
`reader of this message is not the intended recipient, or the employee or agent responsible to deliver it to the intended
`recipient, you are hereby notified that any dissemination, distribution or copying of this communication is strictly
`prohibited. If you have received this communication in error, please immediately notify us by email, postmaster@weil.com,
`and destroy the original message. Thank you.
`
`*******************************************************************
`This message was sent from Goodwin Procter LLP and is intended only for the designated recipient(s). It may
`contain confidential or proprietary information and may be subject to the attorney-client privilege or other
`confidentiality protections. If you are not a designated recipient, you may not review, copy or distribute this
`message. If you receive this in error, please notify the sender by reply e-mail and delete this message. Thank
`you.
`*******************************************************************
`
`2
`
`Regeneron Exhibit 1066.002
`Regeneron v. Novartis
`IPR2020-01318
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
